Evaluating infectious disease forecasts in a cost-loss situation
Philip Gerlee, Torbjörn Lundh, Anna Saxne Jöud, Henrik Thorén
TL;DR
The paper addresses the mismatch between traditional forecast evaluation and decision-making needs by introducing a cost–loss based Value Score (VS) that quantifies the economic value of epidemic forecasts relative to a historical baseline. By applying VS to FluSight influenza peak forecasts, the authors show that several models provide added value for certain cost–loss ratios, even when not top-ranked by conventional scores, and that VS is sensitive to over- vs under-prediction and forecast timing. The work highlights the importance of context-aware evaluation for decision-makers and discusses extensions to more realistic losses and larger datasets. Overall, the VS framework offers a practical, decision-centric metric to guide the utilization and comparison of epidemic forecasts in policy settings.
Abstract
In order for epidemiological forecasts to be useful for decision-makers the forecasts need to be properly validated and evaluated. Although several metrics fore evaluation have been proposed and used none of them account for the potential costs and losses that the decision-maker faces. We have adapted a decision-theoretic framework to an epidemiological context which assigns a Value Score (VS) to each model by comparing the expected expense of the decision-maker when acting on the model forecast to the expected expense obtained from acting on historical event probabilities. The VS depends on the cost-loss ratio and a positive VS implies added value for the decision-maker whereas a negative VS means that historical event probabilities outperform the model forecasts. We apply this framework to a subset of model forecasts of influenza peak intensity from the FluSight Challenge and show that most models exhibit a positive VS for some range of cost-loss ratios. However, there is no clear relationship between the VS and the original ranking of the model forecasts obtained using a modified log score. This is in part explained by the fact that the VS is sensitive to over- vs. under-prediction, which is not the case for standard evaluation metrics. We believe that this type of context-sensitive evaluation will lead to improved utilisation of epidemiological forecasts by decision-makers.
